Skip to main content
Published locations for Allo-SCT remains the only treatment tied to improved survival in atypical CML
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Allo-SCT remains the only treatment tied to improved survival in atypical CML
User login
Username
Password
Reset your password
/content/allo-sct-remains-only-treatment-tied-improved-survival-atypical-cml
/hematology-oncology/article/241291/cml/allo-sct-remains-only-treatment-tied-improved-survival